Literature DB >> 18990714

Physical manifestations of neurodevelopmental disruption: are minor physical anomalies part of the syndrome of schizophrenia?

Michael T Compton1, Elaine F Walker.   

Abstract

The well-documented excess of minor physical anomalies (MPAs) among individuals with schizophrenia generally supports the neurodevelopmental model, which posits that both genetic and environmental factors contribute to structural and functional brain changes in the intrauterine and perinatal periods that predispose one to developing schizophrenia. This review synthesizes select areas of research findings on MPAs to address the question, Are MPAs part of the syndrome of schizophrenia? Although MPAs are not specific to schizophrenia, their presence in some patients indicates that aberrations in the development of the nervous system contribute to risk for the disorder. The broadly defined, heterogeneous MPA construct may be of limited value in further elucidating the specific pathophysiology of schizophrenia, though particular anomalies, such as those pertaining to nasal volumes, palatal abnormalities, or craniofacial morphology, may be informative. Given the availability of more sophisticated microarray technologies, and in light of recent findings on spontaneous mutations in patients with schizophrenia, it is possible that MPAs will prove to be useful in identifying etiologic subtypes and/or the loci of genetic risk factors. It remains to be determined whether MPAs-which, of course, are fixed markers present throughout childhood and adolescence well before the onset of the prodrome and psychosis-may have utility in terms of risk stratification for future preventive efforts. Taken together, research findings on MPAs indicate that these minor anomalies are indeed part of some schizophrenia syndromes, representing a stable systemic or physical set of manifestations of the underlying neurodevelopmental processes that lead to the illness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990714      PMCID: PMC2659308          DOI: 10.1093/schbul/sbn151

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  95 in total

1.  Dermatoglyphics and schizophrenia: findings from the Edinburgh high risk study.

Authors:  Nathan Langsley; Patrick Miller; Majella Byrne; Stephen M Lawrie; Andrew McIntosh; Eve C Johnstone
Journal:  Schizophr Res       Date:  2005-04-01       Impact factor: 4.939

Review 2.  Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia.

Authors:  Joana Almeida Palha; Ann B Goodman
Journal:  Brain Res Rev       Date:  2005-12-01

Review 3.  Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders.

Authors:  T Kato; K Iwamoto; C Kakiuchi; G Kuratomi; Y Okazaki
Journal:  Mol Psychiatry       Date:  2005-07       Impact factor: 15.992

4.  Extralimital triradii as a putative marker of schizotypy.

Authors:  James T Chok; Thomas R Kwapil
Journal:  Schizophr Res       Date:  2005-07-15       Impact factor: 4.939

5.  Craniofacial dysmorphology in Swedish schizophrenia patients.

Authors:  B D Kelly; A Lane; I Agartz; K M Henriksson; T F McNeil
Journal:  Acta Psychiatr Scand       Date:  2005-03       Impact factor: 6.392

6.  A three-dimensional morphometric study of craniofacial shape in schizophrenia.

Authors:  Peter F Buckley; David Dean; Fred L Bookstein; Seungho Han; Michael Yerukhimovich; Kyoung-June Min; Beth Singer
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

7.  No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies.

Authors:  Eun-Jeong Joo; Seong-Hoon Jeong; Yong-Min Ahn; Kyu-Young Lee; Se Chang Yoon; Eui-Joong Kim; Seon-Uk Kim; Soo-Churl Cho; Yong Sik Kim
Journal:  Psychiatry Res       Date:  2005-09-15       Impact factor: 3.222

8.  Dermatoglyphics and Schizophrenia: a meta-analysis and investigation of the impact of obstetric complications upon a-b ridge count.

Authors:  Elvira Bramon; Muriel Walshe; Colm McDonald; Beatriz Martín; Timothea Toulopoulou; Harvey Wickham; Jim van Os; Paul Fearon; Pak C Sham; Lourdes Fañanás; Robin M Murray
Journal:  Schizophr Res       Date:  2005-06-15       Impact factor: 4.939

9.  Birthweight-discordance and differences in early parenting relate to monozygotic twin differences in behaviour problems and academic achievement at age 7.

Authors:  Kathryn Asbury; Judith F Dunn; Robert Plomin
Journal:  Dev Sci       Date:  2006-03

10.  Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene.

Authors:  Jonathan Mill; Emma Dempster; Avshalom Caspi; Benjamin Williams; Terrie Moffitt; Ian Craig
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

View more
  24 in total

1.  Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizophrenia-spectrum disorder: a high-risk prospective investigation.

Authors:  Shana Golembo-Smith; Jason Schiffman; Emily Kline; Holger J Sørensen; Erik L Mortensen; Laura Stapleton; Kentaro Hayashi; Niels M Michelsen; Morten Ekstrøm; Sarnoff Mednick
Journal:  Schizophr Res       Date:  2012-06-02       Impact factor: 4.939

2.  Schizophrenia as a systemic disease.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2009-02-04       Impact factor: 9.306

3.  Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).

Authors:  S T Narla; Y-W Lee; C A Benson; P Sarder; K J Brennand; E K Stachowiak; M K Stachowiak
Journal:  Schizophr Res       Date:  2017-01-13       Impact factor: 4.939

Review 4.  Suckling, Feeding, and Swallowing: Behaviors, Circuits, and Targets for Neurodevelopmental Pathology.

Authors:  Thomas M Maynard; Irene E Zohn; Sally A Moody; Anthony-S LaMantia
Journal:  Annu Rev Neurosci       Date:  2020-02-26       Impact factor: 12.449

5.  Fluctuating dermatoglyphic asymmetries in youth at ultrahigh-risk for psychotic disorders.

Authors:  Olivia Diane Fern Russak; Lindsay Ives; Vijay A Mittal; Derek J Dean
Journal:  Schizophr Res       Date:  2015-12-23       Impact factor: 4.939

6.  Frontonasal dysmorphology in bipolar disorder by 3D laser surface imaging and geometric morphometrics: comparisons with schizophrenia.

Authors:  Robin J Hennessy; Patrizia A Baldwin; David J Browne; Anthony Kinsella; John L Waddington
Journal:  Schizophr Res       Date:  2010-05-31       Impact factor: 4.939

7.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

8.  Developmental instability in social anhedonia: an examination of minor physical anomalies and clinical characteristics.

Authors:  Jack J Blanchard; Minu Aghevli; Amy Wilson; Marsha Sargeant
Journal:  Schizophr Res       Date:  2009-11-27       Impact factor: 4.939

9.  Premorbid multivariate prediction of adult psychosis-spectrum disorder: A high-risk prospective investigation.

Authors:  Jason Schiffman; Emily Kline; Nicole D Jameson; Holger J Sorensen; Shana Dodge; Thomas Tsuji; Erik L Mortensen; Sarnoff A Mednick
Journal:  Schizophr Res       Date:  2015-07-23       Impact factor: 4.939

Review 10.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.